PALM CITY, Fla., March 23 /PRNewswire-FirstCall/ -- Connectyx Technologies Holdings Group, Inc. (OTCPK: CTYX) is pleasedto announce that the Company has appointed Dr. James R. Taylor to its Board of Advisors. Dr. Taylor is an expert in the healthcare and pharmaceutical field. He has written several publications; in addition, he has conducted
Connectyx sponsored a research project with the University of Florida; which Dr. Jim Taylor, the principal investigator for the University of Florida was significantly involved with. The purpose of this research was to document the effectiveness of using an electronic Personal Health Record (ePHR) in a medically underserved population. The project may further the instructional and research objectives of UF. Both Connectyx and the university may derive benefits through inventions, improvements and/or discoveries.
Dr. Taylor, PharmD is a Clinical Associate Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida. He received his doctor of pharmacy degree from Ohio Northern University. Upon graduation, he completed an ASHP accredited Pharmacy Practice Residency at The Veterans Affairs Medical Center in Huntington, West Virginia. Subsequently, he completed a Family Medicine Residency at the University of Florida. Dr. Taylor joined the faculty at the University of Florida in July 1998. Dr. Taylor maintains several active clinical pharmacy practice sites in ambulatory care, including diabetes and anticoagulation. He also offers an Ambulatory Care residency based out of his clinical practice site. He has given numerous professional presentations on diabetes and other primary care topics.
Numerous presentations by Dr. Taylor have been viewed by students and professionals at various places including The Institute of Food and Agricultural Sciences, Ken Finger Memorial, American College of Clinical Pharmacy, University of Florida College of Pharmacy, Annual Pharmacy and Law Management Conference, American Association of Colleges of Pharmacy, and Walgreens pharmacists conference. In addition he has over twenty four publications on diabetes, insomnia, Deep Vein thrombosis and many other primary care topics.
"Dr. Taylor's expertise in the pharmaceutical and Healthcare field provides our organization with the imperative experience we need to continuously expand into new vertical markets. He will be a valuable addition to help our company reach the next level," stated Ronn Schuman, President and CEO of Connectyx Technologies Holdings Group, Inc.
About Connectyx Technologies Holdings Group, Inc.
Connectyx Technologies provides unique products for the healthcare market including, MedFlash, the electronic Personal Health Manager (PHM). Compatible with Google Health and Microsoft's Health Vault, The MedFlash PHM is an easy to use Personal Health and Lifestyle Manager that is accessible using a powerful web portal suite. The MedFlash PHM also features a 24/7/365 call center, a USB flash drive and our (soon to be released) smart phone applications. The MedFlash PHM provides member benefits including instant access to your Emergency Medical Profile and Personal Health Record in the event of an accident or a medical emergency. Whether traveling, at work, or at home, First Responders have an invaluable advantage when they have access to this time critical information. Far more than just an emergency flash drive, The MedFlash PHM can be accessed on any computer, securely and with complete privacy. There are also lifestyle and wellness features that provide significant health benefits to members and risk mitigation for employers and insurers alike.
MedFlash members arrive at their Doctors offices with their paperwork pre-printed and ready to go. Insurance information and advance directives are available at a moment's notice through Instant Medical History, a leader in patient interview software and a MedFlash PHM technology partner. Prescriptions can also be listed for the physician's reference. Those are just a few of the time saving and risk mitigation features the MedFlash PHM provides. Connectyx products are developed with the needs of Patients, Families, Doctors and First Responders in mind. For more information, please visit our websites at: www.connectyx.com and www.medflash.com
Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
SOURCE Connectyx Technologies Holdings Group, Inc.
Subscribe to our Free Newsletters!
Reflux nephropathy is the scarring and damage caused to the kidneys by reverse flow of urine from ...
Drug abuse is a negative social trend that pushes youth to drug addiction in the pretext of getting ...
Proper understanding of waste collection, segregation and management is required to reduce the ...View All